Company Overview

Document Types: Notice convening the 8th Annual General Meeting and Integrated Annual Report for FY 2025-26, and Standalone Financial Statements for year ended March 31, 2026

Financial Performance Highlights

Consolidated Performance (FY 2025-26)

  • Revenue from Operations: ₹124.52 crore (77.31% growth from FY25 ₹70.23 crore)
  • EBITDA: ₹29.28 crore (80% growth from FY25 ₹16.25 crore)
  • Profit After Tax: ₹14.60 crore (90.03% growth from FY25 ₹7.68 crore)
  • EBITDA Margin: 23.5% (improved from 23.1% in FY25)
  • PAT Margin: 11.7% (improved from 10.9% in FY25)

Standalone Performance (FY 2025-26)

  • Revenue from Operations: ₹67.62 crore (47.44% growth from FY25 ₹45.86 crore)
  • Profit After Tax: ₹7.96 crore (50.75% growth from FY25 ₹5.28 crore)
  • EPS: ₹7.30 (FY25: ₹5.94)
  • Total Assets: ₹224.57 crore (doubled from previous year)

Auditor's Opinion

Auditors issued an unqualified opinion confirming the financial statements give a true and fair view in accordance with accounting standards and Companies Act, 2013. Key findings include:

  • Related party transactions comply with Sections 177 and 188 of Companies Act
  • Adequate internal audit system and financial controls operating effectively
  • Full CSR amount spent as required
  • No material uncertainty regarding meeting liabilities
  • No cash losses incurred in current or previous financial year

Business Operations Update

Laboratory Network Expansion

  • Total Laboratories: 16 (10 owned + 6 PPP arrangements)
  • Employee Strength: 1,200+ employees including 450+ scientists
  • Testing Capacity: 5+ million tests annually
  • Laboratory Area: 290,000 sq. ft.

Strategic Acquisitions & Investments

  • Interstellar Testing Centre Private Limited: Became wholly-owned subsidiary through share swap arrangement
  • Food Testing Laboratory, Mumbai: Acquired by slump sale for ₹8.82 crore
  • USFDA-approved Pharmaceutical Laboratory, Bengaluru: Acquired during FY26
  • LabOps Global Private Limited: 74% acquisition for ₹7,400

New Capabilities

  • Received NABCB accreditation under ISO/IEC 17020:2012 for Inspection Services
  • Expanded into mining, metals, railway supply chains, defense inspection
  • Strengthened digital capabilities with LIMS implementation

AGM Details

  • Date: September 25, 2026
  • Time: 11:30 AM IST
  • Venue: Avanta Business Centre, New Delhi
  • Remote E-voting: September 22-24, 2026

Special Business Items

  • Approval for related party transactions including corporate guarantees exceeding ₹12.45 crore threshold
  • Increase overall managerial remuneration limit from 28% to 35% of net profits

Corporate Actions

Share Capital Changes

  • Preferential Allotment: Issued 16,72,531 equity shares for consideration other than cash (share swap)
  • Allottees: TIC Services Private Limited (11,70,881 shares) and Mr. Sanjiv Khullar (5,01,650 shares)
  • Issue Price: ₹310.89 per share

Financial Position & Ratios

  • Total Consolidated Assets: ₹270.95 crore
  • Cash & Cash Equivalents: ₹5.55 crore
  • Long-term Borrowings: ₹60.12 crore
  • Current ratio: 0.92 (FY25: 0.96)
  • Debt-equity ratio: 0.45 (FY25: 0.33)
  • Return on equity: 6.9% (FY25: 8.9%)

Forward Outlook

FY 2026-27 Guidance

  • Revenue Growth: 35-40% over FY26 base
  • EBITDA Margin: 25-27%
  • PAT Margin: 14-15%

Medium-term Ambition

  • Achieve ₹500+ crore consolidated revenue by FY31
  • Improve operating margins and cash generation
  • Expand international business